EUVIMEDEUVIMED entdecken
Crossref

Zanubrutinib mitigates pulmonary fibrosis in aged mice by targeting the Wnt/β-catenin signaling pathway

Zhigang Liu, Lingxin Meng, Bo Yang, Yayue Hu, Zhongyi Yang, Yuming Liu, Ran Jiao, Xueze Liu, Hailong Li, Xiaohe Li, Qingguo Di, Honggang Zhou

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2025.117428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Zhigang Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300353, China. Hauptthemen laut MEDLINE: Pyrimidines, Wnt Signaling Pathway, Piperidines, Pyrazoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Tianjin Municipal Health Commission, Natural Science Foundation of Tianjin Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrotic lung disease characterized by a poor survival prognosis of only 3-5 years post-diagnosis and limited treatment options. Notably, the incidence of IPF is particularly high among the elderly population. Zanubrutinib is a second-generation Bruton's tyrosine kinase (BTK) inhibitor independently developed by BeOne Medicines Ltd, which is approved by the FDA for a variety of B-cell lymphomas, including mantle-cell lymphoma. In this study, we discuss the potential effects and mechanisms of Zanubrutinib on aging lung fibrosis in vivo and in vitro. In vivo studies demonstrated that Zanubrutinib could effectively alleviate bleomycin-induced pulmonary fibrosis in senescent mice and significantly reduce the expression of fibrosis markers and senescence markers. In vivo studies demonstrated that Zanubrutinib inhibited the fibrotic phenotype as well as the senescent phenotype of mouse fibroblasts and mouse epithelial cells. Zanubrutinib effectively inhibited BTK phosphorylation and Wnt/β-catenin signaling pathway transduction, and reduced β-catenin entry into the nucleus. In conclusion, Zanubrutinib may alleviate the senescence-associated phenotype and mitigate senescence-associated pulmonary fibrosis by inhibiting the Wnt/β-catenin signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesWnt Signaling PathwayPiperidinesPyrazolesPulmonary FibrosisAgingAnimalsMiceAgammaglobulinaemia Tyrosine KinaseMice, Inbred C57BLBleomycinMaleCellular SenescenceProtein Kinase Inhibitorsbeta Catenin

Stichwörter der Autor:innen

AgingBruton’s tyrosine kinaseIdiopathic pulmonary fibrosisWnt/β-cateninZanubrutinib

Substanzen

PyrimidinesPiperidineszanubrutinibPyrazolesAgammaglobulinaemia Tyrosine KinaseBleomycinProtein Kinase Inhibitorsbeta Catenin

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300353, China.
  • Department of Thoracic Surgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, China.
  • State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300353, China; Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, T…
  • Department of Respiratory and Critical Care Medicine, Cangzhou Central Hospital, No. 16, Xinhua West Road, Yunhe District, Cangzhou City, Hebei Province 061000, China. Electronic address: dzhqg@126.com.

Förderung

  • Tianjin Municipal Health Commission
  • Natural Science Foundation of Tianjin Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Z., Meng, L., Yang, B., Hu, Y., Yang, Z., Liu, Y., Jiao, R., Liu, X., Li, H., Li, X., Di, Q., & Zhou, H. (2026). Zanubrutinib mitigates pulmonary fibrosis in aged mice by targeting the Wnt/β-catenin signaling pathway. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117428

Vancouver

Liu Z, Meng L, Yang B, Hu Y, Yang Z, Liu Y, et al. Zanubrutinib mitigates pulmonary fibrosis in aged mice by targeting the Wnt/β-catenin signaling pathway. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2025.117428

BibTeX
@article{Liu2026,
  author = {Liu, Zhigang and Meng, Lingxin and Yang, Bo and Hu, Yayue and Yang, Zhongyi and Liu, Yuming and Jiao, Ran and Liu, Xueze and Li, Hailong and Li, Xiaohe and Di, Qingguo and Zhou, Honggang},
  title = {Zanubrutinib mitigates pulmonary fibrosis in aged mice by targeting the Wnt/β-catenin signaling pathway},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2025.117428}
}
Kostenlos starten →